Soiken Holdings Inc.
Notice Regarding the Introduction of a Restricted Stock Unit System
A restricted stock unit compensation system is being newly established. A monetary claim will be granted to eligible directors as consideration in kind, with ordinary shares issued or disposed. The total amount cap is 3,000 million yen per year, and the total number of shares issued is up to 15,000 shares per year; a transfer restriction period and conditions for gratuitous acquisition are set. Approval by the shareholders' meeting scheduled for September 25, 2026 is assumed.
Key Figures
- Annual monetary claim cap: 3,000百万円以内
- Total number of ordinary shares issued/disposed: 年1.50万株以内
- Approval date: 2026年9月25日開催予定の株主総会
AI要約
Purpose and overview of the system
This system aims to enhance corporate value on a sustainable basis and share value with shareholders by granting restricted stock unit compensation to targeted directors. The monetary claims paid will be used as in-kind contributed assets to subscribe for and issue or dispose of our ordinary shares. The subscription price will be set based on the closing price immediately prior to the resolution date, within a scope that avoids any particular advantages. During the transfer restriction period, transfers and pledge arrangements are prohibited, and a contract may be concluded in which the company may acquire shares gratuitously under certain conditions.
Future procedures and approval
Specific timing and allocation of grants to targeted directors will be decided by the board of directors' resolution. The agenda related to the introduction of this system will be submitted to the 32nd Annual General Meeting of Shareholders scheduled for September 25, 2026, and will be subject to shareholders' approval. If a stock split or stock consolidation occurs, the total number will be adjusted within a reasonable range.
Total Medical Research Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
